AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Divalcad 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Cadila Pharmaceuticals Ltd

Salt Composition

Divalproex (750mg)

Overview Divalcad 750mg Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for the extended-release Divalcad 750mg tablet. It's also sometimes prescribed for bipolar disorder management, either independently or as part of a broader medication regimen. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer consistently at the same time daily, with or without food, for maximum therapeutic effect; noticeable improvement typically takes several weeks. Continuous use, as directed, is crucial; missed doses or abrupt cessation can worsen the underlying condition and potentially trigger seizures. Gradual discontinuation under medical supervision is essential. Common adverse effects, often mild, include headache, visual blurring, nausea, vomiting, vertigo, fatigue, gait instability, easy bruising, and hypothermia. Persistent or bothersome side effects should be reported to your doctor; skin rashes require immediate medical attention. Long-term use might lead to osteoporosis and increased fracture risk. Suicidal ideation or behavioral changes are rare but necessitate prompt medical consultation should they occur. Prior to commencing treatment, inform your physician of any pre-existing heart, kidney, or liver conditions, urinary issues, depressive history, or suicidal tendencies. Potential drug interactions exist; comprehensive disclosure of all current medications is vital for safe use. Pregnancy necessitates consultation with your doctor before initiating or discontinuing Divalcad 750mg. Alcohol consumption should be minimized due to the risk of intensified side effects and increased seizure susceptibility. Regular blood monitoring, both pre- and post-treatment, assists in dose optimization.

Primary Ingredients of Divalcad 750mg Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Divalcad 750mg Tablet ER

Managing epileptic seizures and bipolar disorder, and migraine prevention.

Major Benefits of Divalcad 750mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 750mg extended-release Divalcad tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended.

Common Side effects of Divalcad 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Divalcad 750mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Divalcad 750mg Extended-Release tablet whole; do not crush, chew, or break it. You can take it with or without food, though consistency is best achieved by administering it at the same time each day.

How Divalcad 750mg Tablet ER works:

Extended-release Divalcad 750mg tablets are used to treat epilepsy. Their mechanism of action involves reducing overactive neuronal firing in the brain, thus managing seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Taking Divalcad 750mg extended-release tablets with alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Divalcad 750mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Divalcad 750mg tablets pose minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no known harm to the infant.

DrivingDrivingUNSAFE

Extended-release Divalcad 750mg tablets can induce adverse reactions that might impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Divalcad 750mg tablets are considered safe for patients with impaired renal function. No alteration of the Divalcad 750mg extended-release tablet dosage is necessary.

LiverLiverUNSAFE

Extended-release Divalcad 750mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Divalcad 750mg Tablet ER :

Should you forget a Divalcad 750mg Extended-Release tablet, ingest it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Divalcad 750mg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Antiepileptic drugs targeting sodium channels

FAQs on Divalcad 750mg Tablet ER

Always consult your doctor before discontinuing Divalcad 750mg Tablet ER. Withdrawal should be gradual and supervised to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Divalcad 750mg Extended-Release tablets may be used to stabilize mood in individuals experiencing rapid mood swings. This is achieved by reducing excessive brain activity associated with these mood changes.
Divalcad 750mg ER tablets can cause weight gain, possibly from increased appetite. Manage your diet and exercise to minimize this. Consult your doctor if weight gain is a concern.
Drowsiness is a possible side effect of Divalcad 750mg ER Tablets. Refrain from driving or operating machinery until you understand its impact on your alertness.
Hair loss is a possible, though usually temporary and dose-related, side effect of Divalproex Sodium 750mg Extended-Release Tablets. Consult your doctor if you experience persistent or bothersome hair loss.
Divalcad 750mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting and regularly during the initial six months, especially for at-risk individuals and those with a history of liver disease.
Refrain from drinking alcohol during your Divalcad 750mg ER treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Prior to commencing Divalcad 750mg Tablet ER treatment, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation studies to minimize the risk of bleeding or bruising. Liver function tests are also recommended before treatment begins and should be monitored regularly during the first six months, particularly for patients with pre-existing liver conditions or those considered high-risk.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Divalcad 750mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems (rapid breathing, shortness of breath, chest pain) are also possible. Seek immediate medical help if an overdose occurs.
Divalcad 750mg Tablet ER
82
MRP 100
18% off